All Studies

In-silico evaluation of Oroxylum indicum vent compounds in the plausible treatment and prevention of nasopharyngeal cancer.

Researchers studied the plant Shyonaka for its anti-inflammatory, pain-relief, and anti-cancer properties. They found it could potentially target proteins related to both EBV replication and NPC proliferation, offering a promising treatment option for NPC patients.

Thrigulla SR et al (2024).
J Ayurveda Integr Med.
PubMed:
38805854

Breviscapine ameliorates autophagy by activating the JAK2/STAT5/BCL2 pathway in a transient cerebral ischemia rat model.

Breviscapine (Bre) from Erigeron breviscapus reduces ischemic brain damage by decreasing excessive autophagy. Activating JAK2/STAT5/BCL2 pathway improves neural recovery. Potential therapy for cerebral ischemia.

Cun Y et al (2024).
J Neuropathol Exp Neurol.
PubMed:
38804899

Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 Symptoms.

Researchers investigated medicinal plants as potential therapies for COVID-19, using quantum sensing methods to analyze their interactions with COVID protein. Results suggest these plants could be effective against COVID-19 symptoms, aiding drug design efforts.

Mollaamin F et al (2024).
Antibodies (Basel).
PubMed:
38804306

Quercetin improves the protection of hydroxysafflor yellow a against cerebral ischemic injury by modulating of blood-brain barrier and src-p-gp-mmp-9 signalling.

HSYA and Quer from a plant protect the blood-brain barrier in stroke, improving outcomes and reducing neural damage. They target specific proteins for potential treatment benefits.

Li X et al (2024).
Heliyon.
PubMed:
38803916

An Assessment of the In Vitro Antioxidant Activity of Cobalt Nanoparticles Synthesized From Millettia pinnata, Butea monosperma, and Madhuca indica Extracts: A Comparative Study.

Ryntathiang I et al (2024).
Cureus.
PubMed:
38803791